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Cl in ica l  psychology in  haemoglobinopath ies:  
Cost  e f fect ive  pathways  to  funding  
Joanne Lloyd, Roshan das Nair a Dot Mackinlay 
This article describes a service evaluation which was used as evidence in a bidfor clinical psychology funding in 
haemoglobinopathies. We present the approach as a promising framework for securing funding in this difficult 
financial climate. 
SICKLE CELL DISEASE (SCD) and 
thalassaemia are inherited blood disorders 
that vary significantly in their presentation 
and treatment but are known collectively as 
`haemoglobinopathies'. SCD is 
characterised by an abnormality in the 
synthesis of normal haemoglobin (De, 
2005). In SCD, abnormally shaped haemo-
globin are responsible for small vessel 
blockages which account for several symp-
toms and complications including acute 
episodes of pain ('crises'), organ failure and 
stroke. UK incidence of SCD is estimated 
to exceed 10,000, making it the most 
common genetic condition in the UK. It is 
most commonly diagnosed in African and 
Caribbean populations. Tha-lassaemia is a 
chronically recessive inherited blood 
disorder most commonly diagnosed in 
Eastern Mediterranean, Asian, and Middle 
Eastern populations. There are several 
different types of thalas-saemia, which vary 
in terms of illness severity and treatment 
intensity. The main types, alpha 
thalassaemia and beta thalas-saemia, differ 
depending on which haemoglobin chain is 
affected. Beta thalassaemia major is a 
severe form causing life threatening 
anaemia which, without medical 
intervention by regular blood transfusions, 
is fatal. 
Psychosocial difficulties are common in 
haemoglobinopathy populations (Molock & 
Belgrave, 1994; Vardarki et al., 2004) and 
neuropsychological difficulties have been 
widely documented in SCD (Berkelhammer 
et al., 2007). The importance of clinical psy-
chology input into services for people with 
SCD and thalassaemia has been recognised 
(Sickle Cell Society, 2008; 2010; UK Thalas-
saemia Society, 2008). Indeed, specialist 
clinical and health psychology services have 
been developed in other centres including 
London, Birmingham and Manchester. At 
the start of this project there was no clinical 
psychology provision for people with SCD 
and thalassaemia in the Nottingham area 
despite a haemoglobinopathy population of 
approximately 140. To secure local funding 
in an uncertain climate, a needs assessment 
was completed, where we provided evidence 
for a service need and produced a toolkit of 
materials to facilitate the future post-holder's 
prompt integration into the service. 
Groundwork 
The project was registered as a service evalu-
ation with Nottingham University Hospital's 
Research and Innovation Department, and 
was carried out by an Assistant Psychologist 
(AP: JL) supervised by two Consultant Clini-
cal Psychologists (CPs: RdN & DM). Our 
project involved a literature review on psy-
chological aspects of haemoglobinopathies, 
information gathering from staff and service 
users about the current service and their 
needs, introducing clinical psychology to the 
haemoglobinopathy team, and offering short 
interventions with some patients. The project 
therefore allowed us to explore how clinical 
psychology was going to be conceptualised 
from service users and healthcare team 
perspectives, to evaluate the need for the 
service, and to examine how the service 
could be configured and delivered, making 
best use of minimal time and resources. 
To introduce service users and staff to 
clinical psychology we attended patient 
involvement days and met regularly with 
both groups. The AP attended paediatric 
and adult outpatient clinics to learn about 
SCD, understand the key psychological 
issues, and explore how a CP would fit in 
with the service. 
Provision of psychological therapies 
Depression and other psychiatric diagnoses 
are common in SCD, with contributing fac-
tors including illness chronicity, the unpre-
dictable nature of crises and various medical 
complications (Molock & Belgrave, 1994). 
With thalassaemia now a chronic condition, 
focus has shifted to the recognition and 
management of psychosocial problems 
resulting from the condition and its intensive 
and demanding treatment regimes (Var-daki 
et al., 2004). Thus, clinical psychology can 
impact service user experiences and effective 
care delivery. 
To highlight the potential of having a 
CP on the team, short-term psychological 
therapies and self-hypnosis were trialled 
with five individuals by a Consultant CP 
(DM) qualified to practice hypnotherapy. 
This was found to be most effective during 
in-patient admissions or when run along-
side haemoglobinopathy outpatient clinics. 
Research at other centres has found 
psychological interventions, such as 
cognitive behavioural therapy, to be both 
clinically and cost effective (Thomas et al., 
2001). Relaxation and self-hypnosis in SCD 
helps decrease stress and anxiety, which are 
known to precipitate and exacerbate crises 
(Dinges et al., 1997). Service user and 
healthcare professional feedback was very 
positive and it was clear that psychological 
approaches would be accepted as an 
adjunctive therapy for managing and 
preventing painful crises. 
Neuropsychology in SCl) 
Neuropsychological deficits resulting from 
clinical or silent strokes in SCD have been 
documented in the paediatric population 
(Berkelhammer et al., 2007). Impairments in 
executive function and attention are 
common indicators of cerebrovasculopathy 
in SCD (Kral et al., 2003). Such impairments 
can affect an individual's ability to access and 
engage with services and complex care 
regimes across the lifespan. In the UK, it is 
recommended that all children with the most 
severe form of SCD, haemoglobin SS 
(HbSS) are screened annually using 
transcranial doppler (TCD) scanning to 
assess the risk of stroke. Although MRI 
scans can detect silent infarcts, it is imprac-
ticable and expensive to scan every child 
regularly. Thus, it is recommended that reg-
ular developmental assessments and neu-
ropsychological screening be conducted. 
Children with abnormal TCD results 
have decreased verbal intelligence and 
executive function compared to children 
with normal or conditional results (Kral et 
al., 2003). Neuropsychological assessment 
of large numbers of children, however, is 
time-consuming and costly. Initially, we 
were uncertain of how many high-risk 
children (with abnormal TCD results) 
would be referred for assessment in a year-
long period. This project enabled us to 
examine the feasibility of testing those with 
abnormal scans over this period with the 
Wechsler Intelligence Scale for Children 
(WISGIV). By completing these tests, we 
were able to demonstrate the feasibility of 
administering full intellectual assessments to 
the small number of high-risk children (n = 
2). The assessments also offered a baseline 
measure, so that pre-morbid measures were 
available should these children suffer 
strokes in the future. 
The literature on adult cognitive deficits 
in SCD is sparse but suggests that 
neuropsychological impairment in some 
adults is likely (Vichinsky et al., 2010). We 
assessed two adults with SCD who pre-
sented with cognitive difficulties impacting 
on their daily life and care regime. Assess-
ments were tailored to each individual's 
presenting complaints. We found the intel-
lectual function of one adult to be within the 
'Extremely Low' range on the Wechsler 
Adult Intelligence Scale (WAIS-IV; Full 
Scale .IQ = 57). Pre-morbidly, this patient 
was estimated to have functioned in the 
 
   
 average to low-average range. Further 
assessments completed by colleagues in the 
adult neuropsychology service found low 
results in numerous domains including 
executive function and short-term memory; 
however, interpretation was complicated by 
variable engagement across the assessment. 
The results were fed back to the care team 
who interpreted them alongside an MRI 
scan which found deep white matter lacu-
nar infarcts. Lacunar infarcts have been 
found in SCD (Hoppe, 2005) and are asso-
ciated with neuropsychological impairment, 
which can worsen over time (Samuelsson et 
al., 1996). 
The second adult did not show MRI 
abnormalities, but performed at the 5th 
percentile overall on the Doors and Peo-
ple Test and below the 5th percentile on 
the Rivermead Behavioural Memory Test. 
The Doors and People test revealed poor 
immediate recall whilst forgetting scores 
were only just below average. This may 
suggest attentional problems or executive 
dysfunction which has been implicated in 
SCD (Kral et al., 2003). Despite these 
neu-ropsychological impairments, no MRI 
abnormalities were found when investi-
gated. This finding is supported by 
Vichin-sky et al. (2010), who suggest that 
neurologically intact SCD patients can 
present with neuropsychological deficits. 
Our assessments provided the team with 
important information which enhanced 
care delivery by confirming the impair -
ments and identifying ways in which to 
improve engagement and understanding. 
The results suggested the need for a wider 
investigation of neuropsychological 
impairments in the adult SCD population, 
which would inform local needs and 
enhance the evidence base.  
Focus group findings 
The focus group provided service user per-
spectives to our case of need. Four individuals 
with SCD attended the discussion, which lasted 
approximately one hour. Informed consent was 
obtained from participants who agreed for 
anonymous quotes to be used in project 
outputs. 
The focus group discussion was facili-
tated by the AP, using a semi-structured 
interview schedule (developed by the team). 
It was audio recorded and transcribed verba-
tim. The transcript was thematically analysed 
by RdN and JL, who independently coded 
the data and came to a consensus on the 
coding and thematic structure. Three main 
themes emerged from the focus group which 
were: existential concerns, stigma, and the 
need for alternative treatments. Here, we 
describe the latter theme, which informs 
practice and was a common theme 
throughout the discussion. In these 
instances, service users explicitly referred to 
aspects of their care that could be improved 
by the inclusion of a clinical psychology 
service. The theme is divided into the 
following sub-themes... 
Dealing with existential issues 
Service users spoke about life and mortality, 
with thoughts about death becoming so 
commonplace that there was some ambivalence 
about how to deal with this. 
R3: When I was a kid... I used to be the most 
maddest... used to go on all sorts of trips and be 
in all types of cold water 'n' stuff - never ever 
suffered from it. And then got older and older 
and then now it's just getting worse and worse. 
And I've started thinking to myself now, how 
old am I going to be when I die? 
RI: Ahl I do that. I think about that all the 
time. 
R4: I'm like: 'Well I might never live past 
sixty anyway.' [laughs] 
While it appears that they use humour to 
cope with this uncomfortable thought, 
service users felt the need to have someone 
they could talk about their fears to. This is 
exemplified here: 
R2: So if there was a service around that 
where, you know, sickle cell people can 
actually go and talk to someone about their 
fears about that [death and dying]. That will 
help them as well. 
Medication 
While all service users had some reservations 
about medication use to control the condi-
tion, and the way in which they were pre-
scribed, all understood and appreciated the 
need for taking some, particularly during 
severe crises. Some tried to avoid taking 
drugs as long as they could help it, but at the 
point of crisis, they did not want other 
forms of intervention: 
RI: No, I mean I wouldn't try anything for 
my crises [because] crises that I'd have to go 
into hospital for I'd definitely, you know, 
because I want it [drugs] [snaps finger] in an 
instance. I wouldn't have the patience to go 
through breathing exercises [R2 & R3 laugh] 
when you're in pain. I just want something 
there and now [laughs]. 
However, when the pain had reduced, they 
were less keen to continue taking medica-
tions, as they often had distressing side-
effects which they felt were not 
acknowledged by clinicians. 
R3: You're drugging me and not asking me 
how these drugs are making me feel. I don't 
know... No, not once have they ever asked 
me 'How does these tablets make you feel? 
How does Tramadol make you feel? How 
does Cycliyzine make you feel? Paracetemol? 
Diclofenac?'. Never once have they asked me 
how the drugs make you feel. Cause it's all 
right them prescribing you drugs and pump-
ing you full of drugs. [But] then you're mind 
ain't right. And you're body ain't right... 
The potential of clinical psychology R3 
spoke positively about an imagery tech-
nique she had been taught as part of our 
project: 
R3: Well she [CP] came, this is a while ago 
now when I was in hospital, and she sat 
beside my bed... And she did this - close your 
eyes breathe, look for this box... whole 
thing... That kinda helped, cause the pain was 
still there but it was kind of far away. 
Sometimes your pain just feels like it's there 
but it's distant. That helped. 
A final excerpt summarises the potential 
of a clinical psychology service for dealing 
with the complex difficulties that this popu-
lation face: 
R1: So the psychology service addresses the 
fact that we feel like frauds, it's an invisible 
disease, nobody understands and we're not 
believed. We're not believed whenever some-
thing is wrong with us, and we're constantly 
having to make life-changing decisions at 
such a young age, and we always have to 
worry about when we're going to die or when 
we are going to get stroke... 
By voicing these experiences, we were able 
to directly represent service users' views 
and opinions to commissioners and treating 
teams. The focus group findings were 
therefore a key piece of evidence in our bid 
for funding. 
The toolkit 
Throughout the project we developed a 
toolkit of materials to enable a newly 
appointed CP to start work promptly. The 
toolkit included: 
 a guide to local haemoglobinopathy 
services; 
 standards and guidelines; 
 clinical psychology leaflet for service 
users; 
 referral forms; 
 psychological screening tools; 
 a transition plan (from paediatric to 
adult services); and 
 staff training materials 
(e.g. painful procedures). 
Conclusions 
Our project concluded with the submission 
of a case of need to the local NHS Spe-
cialist Commissioning Group. A meeting 
was then held with the commissioning 
group's Strategy and Planning Team who, 
following our work, confirmed funding for 
a CP to work within the team. This project 
was unique in that it enabled substantial 
groundwork to be completed prior to the 
implementation of the service. Discussion 
with others working in the speciality and 
   
previous work by Thomas et al. (2009) has highlighted the value of conducting this type of 
groundwork prior to setting up and delivering a service. Therefore, by employing an AP for 
a time-limited period, we were able to set up the service in a cost-effective manner. 
In haemoglobinopathy services clinical psychology equips people with the skills required to 
cope effectively with their condition, with the aim of reducing hospital admissions, increasing 
adherence, and improving quality of life. Our service evaluation identified the key issues and 
needs of this population, and allowed us to establish links and introduce clinical psychology to 
the team and service users. This process facilitated a straightforward bid for funding, which 
proved a success. 
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